临床SYNTAX评分在冠状动脉血运重建中预测生存优于SYNTAX评分
该研究为以色列前瞻性全国注册研究MULTICAD的子分析,纳入585例左主干和/或2-3支冠状动脉病变患者,随访5年。结果显示,临床SYNTAX评分(CSS)≥27组生存概率较低,且在高CSS患者中,冠状动脉旁路移植术(CABG)的5年死亡率(16.8%)低于经皮冠状动脉介入治疗(PCI)(32.2%);CSS对5年死亡预测的曲线下面积优于SYNTAX评分(SS)。
要点
- CSS≥27与较低生存概率相关,尤其在接受PCI的患者中。
- 高CSS患者中,CABG的5年死亡率16.8%,低于PCI的32.2%。
- CSS预测5年死亡优于SS,曲线下面积更高。
核心结论
- 在真实世界多支病变血运重建患者中,CSS是比SS更好的血运重建后生存预测工具。
- CSS≥27患者中,CABG与PCI相比与更好的全因死亡结局相关。
研究设计与样本
- 研究为以色列前瞻性全国注册研究MULTICAD的子分析,连续纳入左主干和/或2-3支冠状动脉病变(累及前降支近段或中段)患者。
- 共纳入585例患者,随访5年;血运重建方式由各医院主治医生选择。
主要发现
- CSS中位数为27,288例患者CSS≥27,该组平均CSS为47.85,平均SS为29.05。
- 治疗后3年和5年,CSS≥27组生存概率较低。
- 在接受PCI的患者中,CSS≥27与较低的生存概率相关(与接受CABG者相比)。
- 高CSS组中,CABG的5年死亡率为16.8%,PCI的5年死亡率为32.2%。
- 在预测5年死亡结局时,CSS优于SS,曲线下面积更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) trial showed that the SYNTAX score (SS) is a useful tool for customizing revascularization treatment for patients with multivessel coronary disease. In the past decade, the Clinical SS (CSS) has emerged as a comprehensive tool. This novel tool considers the SS as well as patient clinical parameters such as age, creatinine clearance, and ejection fraction, which were shown to be relevant for patient prognosis. Thus, in the current work we set out to compare the survival predictive values of the SS versus the CSS and their future application in real-world implementation of the revascularization guidelines. METHODS: This study was a subanalysis of data collected in a prospective national registry in Israel that enrolled consecutive patients with left main and/or 2- to 3-vessel coronary artery disease involving the proximal or mid-left anterior descending artery; the MULTI-vessel Coronary Artery Disease (MULTICAD). The revascularization method was chosen by the physicians taking care of the patients at each hospital and the patients were followed for 5 years. Patients were categorized according to their SS, the CSS, and their revascularization method (primary coronary intervention [PCI] vs coronary artery bypass grafting [CABG]) and patient survival were compared. RESULTS: A total of 585 patients were enrolled in the study and were followed for 5 years. The median CSS was 27, with 288 patients showing a CSS ≥27, with a mean CSS of 47.85 and a mean SS of 29.05. At 3 and 5 years post-treatment, the CSS ≥27 group had a lower survival probability, CSS ≥27 was associated with a lower survival probability among patients who underwent PCI compared with those who underwent CABG. More specifically, the high-CSS CABG group had a 5-year mortality rate of 16.8%, whereas the high-CSS PCI group had a 5-year mortality rate of 32.2%. In a comparison of SS with CSS for the 5-year mortality outcome prediction, CSS was superior to SS with a higher area under the curve. CONCLUSIONS: This prospective registry of real-world revascularization strategies in patients with multivessel disease showed that CSS is a better predictive tool of postrevascularization survival than SS. Moreover, it showed that surgical revascularization in patients with CSS ≥27 is associated with better all-cause mortality outcome after CABG as compared with after PCI. This attests to the need for a score that considers clinical parameters in a real-world scenario.
引用
- Barac YD, Witberg G, Assali A, et al. The Clinical SYNTAX score predicts survival better than the SYNTAX score in coronary revascularization. J Thorac Cardiovasc Surg. 2022. PMID: 35331554. doi:10.1016/j.jtcvs.2022.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。